**Question:** All of the following statements are true about paxilline are true except

A. Paxilline is a bioactive alkaloid isolated from the plant Hallucinogenic Banana Mushroom (Paxillus involutus).
B. Paxilline inhibits calcineurin, a calcium-dependent serine/threonine protein phosphatase.
C. Paxilline is a potent antagonist of the serotonin 5-HT2A receptor.
D. Paxilline is a competitive inhibitor of the NMDA receptor.

**Correct Answer: D. Paxilline is a competitive inhibitor of the NMDA receptor.**

**Core Concept:** Paxilline is a bioactive alkaloid isolated from the plant Hallucinogenic Banana Mushroom (Paxillus involutus). It is one of multiple bioactive compounds found in this fungus, which is known for its hallucinogenic effects when consumed.

**Why the Correct Answer is Right:** Paxilline is a competitive inhibitor of the NMDA (N-methyl-D-aspartate) receptor. NMDA receptors are glutamate receptors that play a crucial role in synaptic plasticity, learning, and memory. Paxilline binds to the NMDA receptor, preventing the binding of the co-agonist NMDA and glycine, thus inhibiting the receptor function.

**Why Each Wrong Option is Incorrect:**

A. While paxilline is a bioactive alkaloid, it is not solely derived from the Hallucinogenic Banana Mushroom (Paxillus involutus). Paxilline can also be found in other fungi and plants.

B. Paxilline inhibits calcineurin, a calcium-dependent serine/threonine protein phosphatase. Although paxilline has been studied for its effects on calcineurin, this option is incorrect because paxilline's primary mode of action is on NMDA receptors, not calcineurin.

C. Paxilline is a potent antagonist of the serotonin 5-HT2A receptor. While paxilline does interact with serotonin receptors, it is a more potent antagonist of the serotonin 5-HT2A receptor, which is unrelated to NMDA receptors.

**Clinical Pearl:** The NMDA receptor is an important target for various neurological disorders, such as Alzheimer's disease and stroke. Understanding the role of NMDA receptors and competitive inhibitors like paxilline can aid in the development of treatments for these conditions.